Brief: Nabriva Therapeutics And Units Enter Asset Purchase Agreement With Sumitomo Pharma
31/07/2023 13:15
July 31 (Reuters) - Nabriva Therapeutics PLC NBRV.O :
* NABRIVA THERAPEUTICS PLC - ON JULY 30, CO, UNITS ENTERED
ASSET
PURCHASE AGREEMENT WITH SUMITOMO PHARMA CO., LTD.
* NABRIVA THERAPEUTICS PLC - PURCHASER AGREED TO PAY TO CO
UPFRONT
CASH PAYMENT OF $15.0 MILLION UPON CLOSING OF TRANSACTION
Further company coverage: NBRV.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Nabriva Therapeutics
See all newsBrief: Nabriva Therapeutics And Units Enter Asset Purchase Agreement With Sumitomo Pharma
Brief: Nabriva Therapeutics Says Received Delisting Determination Letter From Nasdaq
Brief: Nabriva Therapeutics Receives Notice Of Delisting Or Failure To Satisfy Continued Listing Rule From Nasdaq
Brief: Nabriva Therapeutics - On Jan 31, Co's Unit Entered Into Letter Agreement With 2 Units Of Merck & Co, About Distribution Agreement, Dated July 15, 2020
Brief: Nabriva Therapeutics Provides Corporate Update